Skip to main content
Visualsonic logo
Account
  • Login
Back
  • Products
    • Products
    • Imaging Systems
      • Vevo F2
      • Vevo F2 LAZR-X20
      • Vevo F2 LT
    • Transducers
      • Browse All Transducers
      • Vevo Optical Fibers and Jackets
    • Vevo LAB Analysis Suite
      • About Vevo LAB
      • Vevo CQ
      • Vevo Strain 2.0
      • Vevo Multiplexer
      • LV Analysis
      • Auto LV
      • Update your Vevo LAB Software
    • Imaging Modes Software
      • High-frequency Ultrasound Imaging
        • 4D-Mode
        • B-Mode
        • 3D-Mode
        • M-Mode
        • Anatomical M-Mode
        • Non-linear Contrast Mode
        • Power Doppler Mode
        • Pulsed-Wave Doppler Mode
        • Color Doppler Mode
        • Tissue Doppler Imaging
        • Digital RF-Mode
        • ECG and Respiration Gating
        • EKV
        • Shear Wave Elastography
      • Photoacoustic Imaging
        • Single Wavelength
        • Oxy-hemo
        • Spectro
        • Multi-wavelength
        • PA EKV
      • Acoustics & Engineering
        • VADA
    • Accessories
      • Vevo Imaging Station
      • Vevo Whole Body Imaging
      • Vevo Animal Monitoring System
      • Vevo Infusion Pump
      • Vevo PHANTOM
      • Vevo BRAIN
      • eBox
    • Contrast Agents
      • Photoacoustic Contrast Agents
        • About PA Contrast Agents
        • Angiostamp™800
      • Ultrasound Contrast Agents
        • Vevo MicroMarker
  • Applications
    • Applications
    • Preclinical
      • Oncology
      • Cardiology
      • Theranostics
      • Vascular Biology
      • Neurobiology
      • Developmental
      • Biomarker/Molecular Imaging
      • Image-guided Injection
      • Ischemia/Reperfusion
      • Drug Discovery and Development
      • Colorectal
      • Urogenital
      • Kidney
      • Liver
      • Fibrosis
      • Pulmonary
      • Pancreas
      • MSK
  • Resources
    • Resources
    • FAQ
    • Education
      • Learning Hub: Online Tutorials
      • Tips and Tricks
      • JoVE Videos
      • Request Training
      • Vevo University
      • In vivo Imaging
    • News and Stories
      • Shared Stories
      • Vevo Blog
      • Research Spotlight
      • Case Studies
    • Grants & Fundings
      • Vevo International Student Awards
      • Grant Support
      • List of Grants & Funding
      • Funded Projects
    • Publications Library
    • Image Gallery
    • Recorded Webinars
    • On Demand Videos
  • Events
    • Events
    • Conferences and Society Meetings
    • Upcoming Webinars
    • Upcoming Workshops
  • Support
    • Support
    • Scientific Support
    • Technical Support
    • Vevo Service Plans
    • Request Training
    • FAQ
  • Our Company
    • Our Company
    • About Us
    • News
    • Our Technology
      • Our Technology
      • Ultra High-Frequency Ultrasound
      • Photoacoustics (PA)
      • Imaging Modes
    • Scientific Advisory Board
    • Patents
  • Contact
    • Contact
    • Contact Us
    • Our Global Offices
    • Maps and Directions
    • Distributors
  • Careers
    • Careers
    • Open Positions at VisualSonics
    • External Job Postings

Search

Publication
Myocardial infarction (MI), the globally leading cause of heart failure, morbidity and mortality, involves post-MI ventricular remodeling, a complex process including acute injury healing, scar formation and global changes in the survivingmyocardium. The …
Read more
Publication
Fibromodulin (FMOD), an ECM small leucine-rich proteoglycan (SLRP), was reported to promote angiogenesis not only during wound healing, but also in optical and cutaneous angiogenesis-dependent diseases. However, whether it plays important roles in tumor …
Read more
Publication
Doxorubicin (DOX) is a highly potent chemotherapeutic agent, but its usage is limited by dose-dependent cardiotoxicity. DOX-induced cardiotoxicity involves increased oxidative stress and activated endoplasmic reticulum-mediated apoptosis. Alginate …
Read more
Publication
We have recently demonstrated that repeated administrations of c-kitPOS cardiac progenitor cells (CPCs) have cumulative beneficial effects in rats with old myocardial infarction (MI), resulting in markedly greater improvement in left ventricular (LV) …
Read more
Publication
Cardiac hypertrophy (CH) is an adaptive pro- cess that exists in two distinct forms and allows the heart to adequately respond to an organism’s needs. The first form of CH is physiological, adaptive and reversible. The second is pathological, irreversible …
Read more
Publication
Background: There is inconclusive evidence about the role of sex as a risk factor for doxorubicin (DOX)-induced cardiotoxicity. Recent experimental studies have shown that adult female rats are protected against DOX-induced cardiotoxicity. However, the …
Read more
Publication
Arrhythmogenic cardiomyopathy (AC) is a hereditary disease leading to sudden cardiac death or heart failure. AC pathology is characterized by cardiomyocyte loss and replacement fibrosis. Our goal was to determine whether cardiomyocytes respond to AC …
Read more
Publication
Deletion of Ca2+/calmodulin-dependent protein kinase II delta (CaMKIIδ) has been shown to protect against in vivo ischemia/reperfusion (I/R) injury. It remains unclearwhich CaMKIIδ isoformsand downstreammechanisms are responsible for the salutary effects …
Read more
Publication
RATIONALE: Sirtuin (SIRT3), a major nicotinamide adenine dinucleotide (NAD(+))-dependent deacetylase in mitochondria, declines with aging and its ablation is associated with accelerated development of cardiovascular diseases. However, the role of SIRT3 in …
Read more
Publication
Pulmonary arterial hypertension (PAH) is a fatal condition for which there is no cure. Dimethyl Fumarate (DMF) is an FDA approved anti-oxidative and anti-inflammatory agent with a favorable safety record. The goal of this study was to assess the …
Read more

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Current page 212
  • Page 213
  • Page 214
  • Page 215
  • Page 216
  • …
  • Next page ››
  • Last page Last »
  • Warranty and Service
  • Product Retirement
  • Security
  • Modern Slavery Act
  • Privacy
  • Terms of Service

Contact

Call us at: 1.866.416.4636 | Europe: +31 20 808 2913 | Subscribe To Our Mailing List


VisualSonics, the VisualSonics logo, Vevo, Vevo MicroMarker and EKV are registered and unregistered trademarks of FUJIFILM Sonosite, Inc. in various jurisdictions. FUJIFILM is a registered trademark of FUJIFILM Corporation in various jurisdictions.

Copyright © 2025 FUJIFILM VisualSonics, Inc. All rights reserved. FUJIFILM VisualSonics, Inc is a subsidiary of FUJIFILM Sonosite, Inc.